Per the agreement, the companies will be combined in an all-stock merger of equals, with the merged company to be named Quintiles IMS Holdings.
The new company seeks to create one of the largest portfolios of healthcare information and to drive insights and efficiencies across the life sciences product lifecycle.
“This combination addresses life science companies’ most pressing needs: to transform the clinical development of innovative medicines, demonstrate the value of these medicines in the real world and drive commercial success,” said Tom Pike, Quintiles CEO, in a statement.
Mr. Pike will become vice chairman of the merged organization, and IMS Health chairman and CEO Ari Bousbib will become chairman and CEO of the merged organization. The company plans to maintain dual headquarters in Danbury, Conn., and Research Triangle Park, N.C.
More articles on health IT:
City of Verona to close Epic’s campus TIF district, will collect $21.2M
24 hospitals, health systems seeking Cerner, MEDITECH, Epic talent
Not-so-sensitive data: The case for unprotected health information
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.